AF
EW icon

Arrow Financial’s Edwards Lifesciences EW Stock Holding History

Arrow Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-72
Closed -$2K – 402
2015
Q4 		$2K Buy
+72
New +$1.87K ﹤0.01% 431

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Arrow Financial's EW Position: Q1 2016 in Review

Arrow Financial sold out of Edwards Lifesciences (EW) in Q1 2016, closing a stake of 72 shares — an estimated $2K sold.

Arrow Financial first reported a position in EW in Q4 2015 and held it in 1 quarter. The position peaked at $2K in Q4 2015. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

  • Arrow Financial reported no remaining Edwards Lifesciences position as of Q1 2016 after selling out during the quarter.
  • Arrow Financial sold 72 Edwards Lifesciences shares in Q1 2016, an estimated $2K.
  • Arrow Financial first reported a position in Edwards Lifesciences in Q4 2015 and held it in 1 quarter.
  • Arrow Financial's Edwards Lifesciences position peaked at $2K in Q4 2015.
  • 659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on Arrow Financial's 13F filing for Q1 2016, filed 4 May 2016.